Location: Home
  • search
  • go
  • Relate News
  • 2/6/2018Pfizer, DL Medicine Enter Drug Discovery Partnership
  • 1/3/2018CDMO CMAB Closes US$38 Million Series A Financing Round
  • 12/20/2017JSR Acquires CRO Crown Bioscience for NT$12B
  • 12/4/2017Biopharmaceutical Manufacturing Growing Rapidly in China
  • 12/4/2017CDMO STA Reports Fast Rising OEM Demand under China's New MAH Program
  • 12/1/2017Basilea Extends License of Antifungal Cresemba with Pfizer To China an...
  • 11/28/2017HITGEN and BI Enter DNA-Encoded Library Based Drug Discovery Research ...
  • 11/22/2017Chinese CRO Market Expected to Rise Fast by 2022
  • 11/22/2017RiboBio and GE Healthcare Forges Partnership for Oligonucleotide Drug ...
  • 11/13/2017Pfizer Divests from Chinese JV with Hisun
  • 11/7/2017Pfizer Builds World's First LEED Platinum Pharma Facility in Dalian
  • 10/30/2017Why Asian CROs are Turning to the European Biotech Market
  • 10/26/2017Shanghai ChemPartner Sponsors Peptide Therapeutic Foundation
  • 10/19/2017India and China Lead Global CMO Market Growth Before 2020
  • 9/22/2017Global Contract Pharmaceutical Manufacturing Market to Reach $94.6B by...
  • 9/22/2017Pfizer Appoints Creative Agency to Boost Viagra Publicity in China as ...
  • 9/22/2017Bellen Raises CNY 250M in Series B Round of Financing
  • 9/19/2017SMEI: Chinese Pharma CRO Market to Grow 21% CAGR by 2020
  • 9/9/2017BGI Secures CLIA Certification for Its Lab in Hong Kong
  • 9/4/2017TPG Buys CRO OPC Holding for A Slice of China's Clinical Trial Boom
  • 9/3/20173SBio Acquires Therapure's Canadian Bio-manufacturing Business
  • 8/7/2017Leo, HitGen Enter Long Term Research Partnership
  • 7/31/2017WuXi PharmaTech Merges Pharma Development and CMO Businesses
  • 7/25/2017STA Signs Supply Agreement with TESARO
  • 7/13/2017Cancer in the Asia-Pacific, a CRO Perspective
  • 6/20/2017ShangPharma Announces Second Milestone in Move for Chinese Stock Listi...
  • 6/15/2017APAC Is the Fastest Growing Market for CRO Industry
  • 4/17/2017HitGen, Pfizer Enter Partnership to Build Novel DELs
  • 3/24/2017ShangPharma Announces Strategic Corporate Restructuring of Shanghai Ch...
  • 3/17/2017Pfizer Announces CFDA Approval of RA Drug Xeljanz in China
  • Page:12/25 Total number of articles:744: [First][<<] [10] [11] [12] [13] [14] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group